VITACILINA BEBE DIAPER RASH- zinc oxide ointment 
Taisho Pharmaceutical California Inc.

----------

Vitacilina Bebe Diaper Rash Ointment

Drug Facts

Active ingredient

Zinc Oxide 40%

Purpose

Skin Protectant

Uses

Warnings

For external use only.

Avoid contact with eyes.

Stop use and ask a doctor if

  • condition worsens
  • symptoms last more than 7 days or clear up and occur again within a few days

Keep out of reach of children.

If swallowed, get medical help or contact a Poison Control Center right away: 800-222-1222.

Directions

Other information

Inactive ingredients

paccohol, coconut butter, corn starch, fragrance, hydroxyethylcellulose, lanolin, methylparaben, mineral oil, petrolatum, polysorbate 20, purified water, shea butter

Package Labeling:

Label

VITACILINA BEBE DIAPER RASH 
zinc oxide ointment
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:81929-002
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
ZINC OXIDE (UNII: SOI2LOH54Z) (ZINC CATION - UNII:13S1S8SF37) ZINC CATION400 mg  in 1 g
Inactive Ingredients
Ingredient NameStrength
ALOE VERA LEAF (UNII: ZY81Z83H0X)  
BUTYLATED HYDROXYANISOLE (UNII: REK4960K2U)  
CETYL ALCOHOL (UNII: 936JST6JCN)  
STARCH, CORN (UNII: O8232NY3SJ)  
HYDROXYETHYL CELLULOSE, UNSPECIFIED (UNII: T4V6TWG28D)  
LANOLIN (UNII: 7EV65EAW6H)  
METHYLPARABEN (UNII: A2I8C7HI9T)  
MINERAL OIL (UNII: T5L8T28FGP)  
PETROLATUM (UNII: 4T6H12BN9U)  
POLYSORBATE 20 (UNII: 7T1F30V5YH)  
WATER (UNII: 059QF0KO0R)  
SHEA BUTTER (UNII: K49155WL9Y)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:81929-002-011 in 1 CARTON07/01/2022
150 g in 1 TUBE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM01607/01/2022
Labeler - Taisho Pharmaceutical California Inc. (603827635)

Revised: 11/2023
Document Id: 09ce5c6f-23ad-7dca-e063-6394a90aa47c
Set id: 6701e929-700e-40a4-9117-81e36577bfe1
Version: 2
Effective Time: 20231110
 
Taisho Pharmaceutical California Inc.